Premaitha Share Discussion Threads

[timojelly] 27/2/2017 17:54

Big fkin lol..

[michaelmouse] 27/2/2017 16:53

They're called day traders, and there's a lot of them about at the moment.

With litigation hanging over the company and the inevitability of further fund raisings (imo) it is a company for the short termers.

Al imho of course.

[hjb1] 27/2/2017 16:39

pity a few weak hands get too excited when it goes up a few %..

[kaka47] 27/2/2017 15:50

£££££

[the shuffle man] 27/2/2017 15:41

Nice one. If they can sort the litigation out we are off to the races !

[twodegrees] 27/2/2017 15:32

I bought another 20,000 last week

[the shuffle man] 27/2/2017 15:28

2 degrees you going to buy more now :-)

[twodegrees] 27/2/2017 15:15

Premaitha is pleased to announce the conditional acquisition of the entire issued share capital of Yourgene. The consideration for the Acquisition is the issue of 76,054,570 new ordinary shares in the Company (the "Acquisition Shares") at a price of 9 pence per share (being the mid-market closing price of the shares on 20 December 2016, the last practicable date prior to announcement of the Acquisition), and cash consideration of US$500,000, to be funded out of Yourgene's existing cash reserves. The Acquisition Shares will represent approximately 25% of the issued ordinary share capital of the Company as enlarged by the Acquisition Shares.

Mayb be I should have re-read it...
Yourgene is a significant Asian NIPT bioinformatics specialist based in Taiwan. It has a commercial hub in Singapore and annual sales of circa GBP2.0 million generated from across South East Asia and India, and is broadly break-even at these trading levels.

A circular (the "Circular") will shortly be posted to Premaitha shareholders seeking approval of the Acquisition, authority for the Directors to issue the Acquisition Shares and approval of the share sub-division.

The Acquisition will become unconditional following the passing of the resolutions to be proposed at the General Meeting, the London Stock Exchange agreeing to admit (subject only to their allotment) the Acquisition Shares to trading on AIM and the granting of the regulatory approval of the Acquisition required by Taiwanese law. This is expected to occur by no later than 31 January 2017.

[the shuffle man] 27/2/2017 15:02

2degrees read the RNS from December 16 which has all the details.

[twodegrees] 27/2/2017 15:00

the only downside is that the company have not released how much it cost them to acquire the acquisition and secondly how much of a premium did premaitha pay to secure this buy out...perhaps if more figures were available stronger interest in purchasing shares would take place....

[timojelly] 27/2/2017 14:44

Only one way this is heading

[andrewsr] 27/2/2017 09:39

Does that now count as a 'break-out' from the 11p level, where there had been resistance? Not a technical trader, but it's good have the charts in your favour.

[mhw28865] 27/2/2017 08:58

Slow and steady over next few months will do me v nicely..

[timojelly] 27/2/2017 08:57

High teens

[hamidahamida] 27/2/2017 08:31

Next stop 15p

[hamidahamida] 27/2/2017 08:30

Come on keep it going

[hjb1] 27/2/2017 08:25

now it's up..lol mm just after your shares!!

[folderboy] 27/2/2017 08:02

Opens down? Oh come on - how can this be bad news?!

[timojelly] 27/2/2017 07:23

Great rns, good news. The compound effect of all these labs coming on board will do wonders for the shareprice in the future.

[deanroberthunt] 24/2/2017 13:00

or just Shareprophets ramping

[timojelly] 24/2/2017 12:23

Something kicking off

[twix386] 24/2/2017 09:26

as always you look to scare and refuse to supply info and need to be called out.
Requiring ME to provide the info you would not.
I accept Premaitha's rationale excluding a small hand-full of false positives for particular Medical Features.
Of course you have nothing more (or anything) material to say by way of providing detail/info yourself.

Same old helpful Dave444 M.O. with an agenda!

[dave444] 24/2/2017 09:15

As always people cannot accept reality!

[twix386] 24/2/2017 09:09

LOL

It's been posted as a link and the article text on LSE (and copied here) as many are not Genomeweb subscribers.

I expect all that was missing originally was the title, which I copied above that mentioned just a small hand-full of false positives in thousands of samples and put down to Biological features.

I also expect the article text was fully copied, but cannot access it.

Dave444, if any different, then please SHOW US specifically?
Otherwise jog-on

[dave444] 24/2/2017 09:03

https://www.genomeweb.com/molecular-diagnostics/premaitha-reports-100-percent-sensitivity-specificity-Iona-nipt-test